ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.
ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.
Cé go gcuireann uirlisí eile am amú, cabhraímid leat cuideachtaí níos oiriúnaí a cháiliú i gceann nóiméad, ionas go bhfanann do phíblíne folláin, go bhfanann d'fhoireann táirgiúil, agus go mbogann do mhargaí níos tapúla.